Pharmacy-Based Buprenorphine Induction
Dr. Jeffrey Bratberg studies the essential and emerging roles community pharmacists play regarding opioid overdose, harm reduction and opioid use disorders as a clinical professor of pharmacy practice at the University of Rhode Island.
1. Recognize the urgent need for barrier-free models of buprenorphine access.
2. Explain the key elements of a novel collaborative model of pharmacy-based buprenorphine induction.
3. Describe the characteristics of the participants in the model.
He works with student pharmacists to advocate for pharmacists’ expanded roles in medication access, public health promotion, and policy change. He is an associate editor of the Journal of the American Pharmacists Association (JAPhA) and is on the Board of Directors of the Association for Multidisciplinary Education and Research in Substance use and Addiction (AMERSA). He also co-produces and hosts a public health pharmacy podcast, "The Regimen."
Click below for the presentation slides.